谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study

N. Leighl,B. C. Cho,S. Hiret,J. -Y. Han,K. H. Lee,C. Llacer Perez,M. G. Krebs,F. De Braud,E. Haura,R. E. Sanborn,J. C. -H. Yang,C. A. Shu,K. Goto,M. Nishio,J. Zhao,Z. Wang,P. Tomasini,E. Felip,J. W. Goldman,S. -H. I. Ou,M. Boyer,G. Gao, S. Qu,J. C. Curtin,X. Lyu,A. Roshak,R. W. Schnepp, P. Kim, J. Mertz,M. Thayu,S. M. Shreeve,R. E. Knoblauch,A. I. Spira

JOURNAL OF THORACIC ONCOLOGY（2023）

引用 0|浏览12
关键词
Amivantamab,MET,NSCLC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要